temozolomide has been researched along with Sarcoma, Synovial in 2 studies
Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)
Excerpt | Relevance | Reference |
---|---|---|
"Synovial sarcoma is a soft-tissue sarcoma and a rare type of cancer." | 1.43 | Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor. ( Kondo, T; Miyamoto, M; Ohta, T; Watanabe, T; Yamamoto, Y; Yamasaki, H, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazan, F | 1 |
Vollmer, I | 1 |
Gayete, A | 1 |
Yamasaki, H | 1 |
Miyamoto, M | 1 |
Yamamoto, Y | 1 |
Kondo, T | 1 |
Watanabe, T | 1 |
Ohta, T | 1 |
2 other studies available for temozolomide and Sarcoma, Synovial
Article | Year |
---|---|
Chemotherapy-induced secondary pneumothorax.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizuma | 2014 |
Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor.
Topics: Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Damage; DNA Repair; Etoposide; Humans; Phthal | 2016 |